SCHEMBL1827687

SCHEMBL1827687

C(=C(OC(=Cc1ccccc1)c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 1/20 0.48
PRMT1 Q99873 1/20 0.44
ESR1 P03372 1/20 0.43
CYP19A1 P11511 2/20 0.42
CYP11B2 P19099 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
TSHR P16473 1/20 0.40
AKR1C3 P42330 1/20 0.40
PLIN1 O60240 1/20 0.39
BCHE P06276 1/20 0.39
TNFRSF1A P19438 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24818499 0.90 AKR1C1 (0.41) AKR1C1PRMT1ESR1CYP19A1CYP11B2
SCHEMBL20440724 0.87 AKR1C1 (0.57) AKR1C1PRMT1MEN1KMT2AALDH1A1
SCHEMBL28558123 0.87 AKR1C1 (0.52) AKR1C1PRMT1MEN1KMT2AALDH1A1
SCHEMBL703633 0.87 AKR1C1 (0.52) AKR1C1PRMT1MEN1KMT2AALDH1A1
SCHEMBL10006253 0.84 AKR1C3 (0.50) AKR1C1MEN1KMT2AALDH1A1LMNA
SCHEMBL4982106 0.84 AKR1C3 (0.50) AKR1C1MEN1KMT2AALDH1A1LMNA
SCHEMBL20440726 0.84 AKR1C1 (0.53) AKR1C1PRMT1MEN1KMT2AALDH1A1
SCHEMBL6027509 0.84 AKR1C1 (0.47) AKR1C1PRMT1ESR1CYP19A1CYP11B2
SCHEMBL819399 0.82 MEN1 (0.46) AKR1C1PRMT1ESR1CYP19A1CYP11B2
SCHEMBL713257 0.82 MEN1 (0.46) AKR1C1PRMT1ESR1CYP19A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252712-B2 Polymer dispersant addition to fuel cell electrode inks for improved manufacturability GM Global Technology Operations LLC (US) 2012-08-28 US disclosed
US-20110117472-A1 POLYMER DISPERSANT ADDITION TO FUEL CELL ELECTRODE INKS FOR IMPROVED MANUFACTURABILITY GM GLOBAL TECHNOLOGY OPERATIONS, INC. (US) 2011-05-19 US disclosed
US-20070015840-A1 Use of an alkyl ether of hydroxystilbene for the treatment of dry skin L'OREAL (FR) 2007-01-18 US disclosed
EP-1575544-A1 USE OF AN ALKYL ETHER OF HYDROXYSTILBENE FOR THE TREATMENT OF DRY SKIN L'OREAL (FR) 2005-09-21 EP disclosed
WO-2004054533-A1 USE OF AN ALKYL ETHER OF HYDROXYSTILBENE FOR THE TREATMENT OF DRY SKIN L'OREAL (FR) 2004-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015840-A1 Use of an alkyl ether of hydroxystilbene for the treatment of dry skin CYP8B1, HSD17B11, HSD17B1 AKR1C1 103/4885PRMT1 4773/4885ESR1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.